HYOU1_HUMAN - dbPTM
HYOU1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID HYOU1_HUMAN
UniProt AC Q9Y4L1
Protein Name Hypoxia up-regulated protein 1
Gene Name HYOU1
Organism Homo sapiens (Human).
Sequence Length 999
Subcellular Localization Endoplasmic reticulum lumen.
Protein Description Has a pivotal role in cytoprotective cellular mechanisms triggered by oxygen deprivation. May play a role as a molecular chaperone and participate in protein folding..
Protein Sequence MADKVRRQRPRRRVCWALVAVLLADLLALSDTLAVMSVDLGSESMKVAIVKPGVPMEIVLNKESRRKTPVIVTLKENERFFGDSAASMAIKNPKATLRYFQHLLGKQADNPHVALYQARFPEHELTFDPQRQTVHFQISSQLQFSPEEVLGMVLNYSRSLAEDFAEQPIKDAVITVPVFFNQAERRAVLQAARMAGLKVLQLINDNTATALSYGVFRRKDINTTAQNIMFYDMGSGSTVCTIVTYQMVKTKEAGMQPQLQIRGVGFDRTLGGLEMELRLRERLAGLFNEQRKGQRAKDVRENPRAMAKLLREANRLKTVLSANADHMAQIEGLMDDVDFKAKVTRVEFEELCADLFERVPGPVQQALQSAEMSLDEIEQVILVGGATRVPRVQEVLLKAVGKEELGKNINADEAAAMGAVYQAAALSKAFKVKPFVVRDAVVYPILVEFTREVEEEPGIHSLKHNKRVLFSRMGPYPQRKVITFNRYSHDFNFHINYGDLGFLGPEDLRVFGSQNLTTVKLKGVGDSFKKYPDYESKGIKAHFNLDESGVLSLDRVESVFETLVEDSAEEESTLTKLGNTISSLFGGGTTPDAKENGTDTVQEEEESPAEGSKDEPGEQVELKEEAEAPVEDGSQPPPPEPKGDATPEGEKATEKENGDKSEAQKPSEKAEAGPEGVAPAPEGEKKQKPARKRRMVEEIGVELVVLDLPDLPEDKLAQSVQKLQDLTLRDLEKQEREKAANSLEAFIFETQDKLYQPEYQEVSTEEQREEISGKLSAASTWLEDEGVGATTVMLKEKLAELRKLCQGLFFRVEERKKWPERLSALDNLLNHSSMFLKGARLIPEMDQIFTEVEMTTLEKVINETWAWKNATLAEQAKLPATEKPVLLSKDIEAKMMALDREVQYLLNKAKFTKPRPRPKDKNGTRAEPPLNASASDQGEKVIPPAGQTEDAEPISEPEKVETGSEPGDTEPLELGGPGAEPEQKEQSTGQKRPLKNDEL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
19UbiquitinationRRVCWALVAVLLADL
HHHHHHHHHHHHHHH
2.40-
51UbiquitinationSMKVAIVKPGVPMEI
EEEEEEECCCCCCEE
29.91-
56SulfoxidationIVKPGVPMEIVLNKE
EECCCCCCEEEECCC
5.2228465586
62UbiquitinationPMEIVLNKESRRKTP
CCEEEECCCCCCCCC
53.56-
752-HydroxyisobutyrylationTPVIVTLKENERFFG
CCEEEEECCCCEECC
49.48-
75AcetylationTPVIVTLKENERFFG
CCEEEEECCCCEECC
49.4826822725
75MalonylationTPVIVTLKENERFFG
CCEEEEECCCCEECC
49.4826320211
75UbiquitinationTPVIVTLKENERFFG
CCEEEEECCCCEECC
49.48-
79MethylationVTLKENERFFGDSAA
EEECCCCEECCCHHH
43.72115480067
88SulfoxidationFGDSAASMAIKNPKA
CCCHHHHHHHCCHHH
3.7121406390
91UbiquitinationSAASMAIKNPKATLR
HHHHHHHCCHHHHHH
58.6321890473
91UbiquitinationSAASMAIKNPKATLR
HHHHHHHCCHHHHHH
58.6321890473
942-HydroxyisobutyrylationSMAIKNPKATLRYFQ
HHHHCCHHHHHHHHH
64.49-
94UbiquitinationSMAIKNPKATLRYFQ
HHHHCCHHHHHHHHH
64.49-
99PhosphorylationNPKATLRYFQHLLGK
CHHHHHHHHHHHHCC
15.6528152594
106UbiquitinationYFQHLLGKQADNPHV
HHHHHHCCCCCCCCE
42.13-
116PhosphorylationDNPHVALYQARFPEH
CCCCEEEEEECCCCC
7.1528152594
155N-linked_GlycosylationEVLGMVLNYSRSLAE
HHHHHHHHHCHHHHH
22.7112754519
155N-linked_GlycosylationEVLGMVLNYSRSLAE
HHHHHHHHHCHHHHH
22.7112754519
170UbiquitinationDFAEQPIKDAVITVP
HHHHCCCCCEEEEHH
46.44-
198AcetylationAARMAGLKVLQLIND
HHHHCCCCEEHHHCC
39.73155333
198UbiquitinationAARMAGLKVLQLIND
HHHHCCCCEEHHHCC
39.73-
207PhosphorylationLQLINDNTATALSYG
EHHHCCCCHHHHHHC
28.4025072903
209PhosphorylationLINDNTATALSYGVF
HHCCCCHHHHHHCEE
26.5425072903
212PhosphorylationDNTATALSYGVFRRK
CCCHHHHHHCEECCC
19.8525072903
213PhosphorylationNTATALSYGVFRRKD
CCHHHHHHCEECCCC
20.4025072903
221UbiquitinationGVFRRKDINTTAQNI
CEECCCCCCCCCCEE
5.75-
222N-linked_GlycosylationVFRRKDINTTAQNIM
EECCCCCCCCCCEEE
41.32UniProtKB CARBOHYD
255SulfoxidationVKTKEAGMQPQLQIR
EECCCCCCCCCEEEE
7.2821406390
262MethylationMQPQLQIRGVGFDRT
CCCCEEEEECCCCCC
22.30115480059
269PhosphorylationRGVGFDRTLGGLEME
EECCCCCCCCHHHHH
31.44-
275SulfoxidationRTLGGLEMELRLRER
CCCCHHHHHHHHHHH
7.6521406390
278MethylationGGLEMELRLRERLAG
CHHHHHHHHHHHHHH
20.56115480083
308AcetylationENPRAMAKLLREANR
HCHHHHHHHHHHHHH
34.6625953088
308UbiquitinationENPRAMAKLLREANR
HCHHHHHHHHHHHHH
34.66-
311UbiquitinationRAMAKLLREANRLKT
HHHHHHHHHHHHHHH
51.9621890473
315UbiquitinationKLLREANRLKTVLSA
HHHHHHHHHHHHHHC
44.61-
369PhosphorylationPVQQALQSAEMSLDE
HHHHHHHHCCCCHHH
27.3520860994
372SulfoxidationQALQSAEMSLDEIEQ
HHHHHCCCCHHHCCE
4.8830846556
373PhosphorylationALQSAEMSLDEIEQV
HHHHCCCCHHHCCEE
24.9521406692
376UbiquitinationSAEMSLDEIEQVILV
HCCCCHHHCCEEEEE
54.44-
387PhosphorylationVILVGGATRVPRVQE
EEEECCCCCCHHHHH
35.1620860994
398UbiquitinationRVQEVLLKAVGKEEL
HHHHHHHHHHCHHHH
36.5421890473
398AcetylationRVQEVLLKAVGKEEL
HHHHHHHHHHCHHHH
36.5427452117
398UbiquitinationRVQEVLLKAVGKEEL
HHHHHHHHHHCHHHH
36.5421890473
4022-HydroxyisobutyrylationVLLKAVGKEELGKNI
HHHHHHCHHHHCCCC
41.22-
402AcetylationVLLKAVGKEELGKNI
HHHHHHCHHHHCCCC
41.2226822725
402UbiquitinationVLLKAVGKEELGKNI
HHHHHHCHHHHCCCC
41.22-
421PhosphorylationAAAMGAVYQAAALSK
HHHHHHHHHHHHHHH
7.60-
431AcetylationAALSKAFKVKPFVVR
HHHHHHHCCCCEEEC
54.9625953088
433UbiquitinationLSKAFKVKPFVVRDA
HHHHHCCCCEEECCC
33.07-
433UbiquitinationLSKAFKVKPFVVRDA
HHHHHCCCCEEECCC
33.07-
443PhosphorylationVVRDAVVYPILVEFT
EECCCCHHHHHEEEE
4.30-
461PhosphorylationEEEPGIHSLKHNKRV
HCCCCCCCCCCCCEE
36.8728450419
463AcetylationEPGIHSLKHNKRVLF
CCCCCCCCCCCEEEE
48.4225825284
463UbiquitinationEPGIHSLKHNKRVLF
CCCCCCCCCCCEEEE
48.42-
515N-linked_GlycosylationLRVFGSQNLTTVKLK
HEEECCCCCEEEEEE
40.8416263699
515N-linked_GlycosylationLRVFGSQNLTTVKLK
HEEECCCCCEEEEEE
40.8416263699
520UbiquitinationSQNLTTVKLKGVGDS
CCCCEEEEEEECCHH
42.25-
522UbiquitinationNLTTVKLKGVGDSFK
CCEEEEEEECCHHHH
45.92-
527PhosphorylationKLKGVGDSFKKYPDY
EEEECCHHHHHCCCC
32.79-
5292-HydroxyisobutyrylationKGVGDSFKKYPDYES
EECCHHHHHCCCCCC
56.18-
529UbiquitinationKGVGDSFKKYPDYES
EECCHHHHHCCCCCC
56.18-
530AcetylationGVGDSFKKYPDYESK
ECCHHHHHCCCCCCC
61.0727178108
531PhosphorylationVGDSFKKYPDYESKG
CCHHHHHCCCCCCCC
11.2628152594
5372-HydroxyisobutyrylationKYPDYESKGIKAHFN
HCCCCCCCCCHHCCC
53.36-
537UbiquitinationKYPDYESKGIKAHFN
HCCCCCCCCCHHCCC
53.36-
562PhosphorylationRVESVFETLVEDSAE
HHHHHHHHHHCCCHH
25.3325693802
567PhosphorylationFETLVEDSAEEESTL
HHHHHCCCHHHHHHH
24.8729255136
572PhosphorylationEDSAEEESTLTKLGN
CCCHHHHHHHHHHHH
31.8129691806
573PhosphorylationDSAEEESTLTKLGNT
CCHHHHHHHHHHHHH
41.5529691806
575PhosphorylationAEEESTLTKLGNTIS
HHHHHHHHHHHHHHH
25.0625693802
580O-linked_GlycosylationTLTKLGNTISSLFGG
HHHHHHHHHHHHHCC
22.0455825385
580PhosphorylationTLTKLGNTISSLFGG
HHHHHHHHHHHHHCC
22.0430622161
582PhosphorylationTKLGNTISSLFGGGT
HHHHHHHHHHHCCCC
20.9625850435
583PhosphorylationKLGNTISSLFGGGTT
HHHHHHHHHHCCCCC
24.7025850435
589O-linked_GlycosylationSSLFGGGTTPDAKEN
HHHHCCCCCCCHHHC
38.1355834607
589PhosphorylationSSLFGGGTTPDAKEN
HHHHCCCCCCCHHHC
38.1325627689
590O-linked_GlycosylationSLFGGGTTPDAKENG
HHHCCCCCCCHHHCC
23.5755834613
590PhosphorylationSLFGGGTTPDAKENG
HHHCCCCCCCHHHCC
23.5725159151
596N-linked_GlycosylationTTPDAKENGTDTVQE
CCCCHHHCCCCCCHH
58.9412754519
596N-linked_GlycosylationTTPDAKENGTDTVQE
CCCCHHHCCCCCCHH
58.9412754519
600PhosphorylationAKENGTDTVQEEEES
HHHCCCCCCHHHHCC
24.75-
634O-linked_GlycosylationEAPVEDGSQPPPPEP
CCCCCCCCCCCCCCC
52.41OGP
634PhosphorylationEAPVEDGSQPPPPEP
CCCCCCCCCCCCCCC
52.4125159151
7222-HydroxyisobutyrylationKLAQSVQKLQDLTLR
HHHHHHHHHHHCCHH
46.06-
727PhosphorylationVQKLQDLTLRDLEKQ
HHHHHHCCHHHHHHH
28.2120068231
738UbiquitinationLEKQEREKAANSLEA
HHHHHHHHHHHHHHH
60.05-
742PhosphorylationEREKAANSLEAFIFE
HHHHHHHHHHHHHHH
23.9027050516
750PhosphorylationLEAFIFETQDKLYQP
HHHHHHHCCCHHCCC
31.1725278378
753UbiquitinationFIFETQDKLYQPEYQ
HHHHCCCHHCCCCHH
39.00-
755PhosphorylationFETQDKLYQPEYQEV
HHCCCHHCCCCHHCC
27.9725278378
759PhosphorylationDKLYQPEYQEVSTEE
CHHCCCCHHCCCCHH
19.3625278378
763PhosphorylationQPEYQEVSTEEQREE
CCCHHCCCCHHHHHH
29.3725278378
764PhosphorylationPEYQEVSTEEQREEI
CCHHCCCCHHHHHHH
49.0325278378
7972-HydroxyisobutyrylationTTVMLKEKLAELRKL
HHHHHHHHHHHHHHH
51.95-
830N-linked_GlycosylationSALDNLLNHSSMFLK
HHHHHHHHHCHHHHH
35.8419522481
830N-linked_GlycosylationSALDNLLNHSSMFLK
HHHHHHHHHCHHHHH
35.8412754519
832O-linked_GlycosylationLDNLLNHSSMFLKGA
HHHHHHHCHHHHHHC
23.5630059200
845SulfoxidationGARLIPEMDQIFTEV
HCCCCHHHHHHHHHH
3.7430846556
850PhosphorylationPEMDQIFTEVEMTTL
HHHHHHHHHHCHHHH
40.53-
854SulfoxidationQIFTEVEMTTLEKVI
HHHHHHCHHHHHHHH
4.1330846556
862N-linked_GlycosylationTTLEKVINETWAWKN
HHHHHHHHHCCHHHC
43.5712754519
862N-linked_GlycosylationTTLEKVINETWAWKN
HHHHHHHHHCCHHHC
43.5712754519
869N-linked_GlycosylationNETWAWKNATLAEQA
HHCCHHHCCCHHHHC
27.70UniProtKB CARBOHYD
869N-linked_GlycosylationNETWAWKNATLAEQA
HHCCHHHCCCHHHHC
27.7016335952
8832-HydroxyisobutyrylationAKLPATEKPVLLSKD
CCCCCCCCCEEECCH
35.75-
883AcetylationAKLPATEKPVLLSKD
CCCCCCCCCEEECCH
35.7525953088
883MalonylationAKLPATEKPVLLSKD
CCCCCCCCCEEECCH
35.7526320211
8892-HydroxyisobutyrylationEKPVLLSKDIEAKMM
CCCEEECCHHHHHHH
63.80-
8942-HydroxyisobutyrylationLSKDIEAKMMALDRE
ECCHHHHHHHHHHHH
19.20-
894AcetylationLSKDIEAKMMALDRE
ECCHHHHHHHHHHHH
19.2026822725
900MethylationAKMMALDREVQYLLN
HHHHHHHHHHHHHHH
47.00115480075
904PhosphorylationALDREVQYLLNKAKF
HHHHHHHHHHHHHCC
20.5228152594
9082-HydroxyisobutyrylationEVQYLLNKAKFTKPR
HHHHHHHHHCCCCCC
53.58-
922N-linked_GlycosylationRPRPKDKNGTRAEPP
CCCCCCCCCCCCCCC
68.17UniProtKB CARBOHYD
931N-linked_GlycosylationTRAEPPLNASASDQG
CCCCCCCCCCCCCCC
37.3117623646
931N-linked_GlycosylationTRAEPPLNASASDQG
CCCCCCCCCCCCCCC
37.3112754519
933O-linked_GlycosylationAEPPLNASASDQGEK
CCCCCCCCCCCCCCC
27.5130059200
948PhosphorylationVIPPAGQTEDAEPIS
CCCCCCCCCCCCCCC
34.6126091039
955PhosphorylationTEDAEPISEPEKVET
CCCCCCCCCCCCCCC
58.7929507054
962PhosphorylationSEPEKVETGSEPGDT
CCCCCCCCCCCCCCC
49.3325627689
964O-linked_GlycosylationPEKVETGSEPGDTEP
CCCCCCCCCCCCCCC
48.30OGP
964PhosphorylationPEKVETGSEPGDTEP
CCCCCCCCCCCCCCC
48.3025627689

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of HYOU1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of HYOU1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of HYOU1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RPAC1_HUMANPOLR1Cphysical
22939629
NUP37_HUMANNUP37physical
22939629
ARMX3_HUMANARMCX3physical
22863883
BCAR1_HUMANBCAR1physical
22863883
BIN1_HUMANBIN1physical
22863883
KI13A_HUMANKIF13Aphysical
22863883
MCM2_HUMANMCM2physical
22863883
MSH6_HUMANMSH6physical
22863883
XRCC5_HUMANXRCC5physical
22863883
XRCC6_HUMANXRCC6physical
22863883
DJB11_HUMANDNAJB11physical
26344197
DNJC7_HUMANDNAJC7physical
26344197
ERF1_HUMANETF1physical
26344197
HXK1_HUMANHK1physical
26344197
HXK2_HUMANHK2physical
26344197
NU205_HUMANNUP205physical
26344197
SE1L1_HUMANSEL1Lphysical
27030672

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of HYOU1_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins.";
Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.;
Nat. Biotechnol. 27:378-386(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-515, AND MASSSPECTROMETRY.
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry.";
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
J. Proteome Res. 8:651-661(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-515; ASN-596; ASN-830;ASN-862 AND ASN-931, AND MASS SPECTROMETRY.
"Elucidation of N-glycosylation sites on human platelet proteins: aglycoproteomic approach.";
Lewandrowski U., Moebius J., Walter U., Sickmann A.;
Mol. Cell. Proteomics 5:226-233(2006).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-515, AND MASSSPECTROMETRY.
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-515; ASN-830; ASN-869 ANDASN-931, AND MASS SPECTROMETRY.
"Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry.";
Zhang H., Li X.-J., Martin D.B., Aebersold R.;
Nat. Biotechnol. 21:660-666(2003).
Cited for: GLYCOSYLATION AT ASN-155; ASN-515; ASN-596; ASN-830; ASN-862 ANDASN-931.

TOP